Risk stratification and real-world management of pediatric AAORCA: discordance between anatomical features and clinical symptoms

• by Jinjin Yu, Shushui Wang, Qinchang Chen, Ping Zhu, Wei Pan

• July 15, 2026

Case Report: The effect of early initiation of eteplirsen treatment on the cardiac and motor disease course in an individual with Duchenne muscular dystrophy

• by Yamen Masalha, Yoav Zehavi, Banan Musallam, Majd Khamaysi, Maali Abu Omer, Daniel L. Fink, Ronen Spiegel

• July 9, 2026

Characteristics Associated with Poor Long-Term Outcomes in Patients with Fontan Palliation: A Case-Control Study

• by Anusha Konduri, Sunkyung Yu, Scott Breshears, Ashley Duimstra, Timothy Lancaster, Vikram Sood, Jennifer Romano, Amanda D. McCormick, Heang M. Lim, David M. Peng, Kurt R. Schumacher

• June 26, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min